Smoking cessation products are now available for pharmacy order on Canview. Log in to learn more.
Australian Natural Therapeutics Group (ANTG) is an Australian‑owned company advancing medicinal cannabis through proprietary genetics, GACP/GMP‑certified operations and evidence‑backed research.
Founded with a personal mission to improve patient outcomes, ANTG delivers consistent, high‑quality products.
Founded in 2016, ANTG was born from a personal mission to improve the lives of patients through high-quality alternative therapies. Founder Matthew Cantelo was inspired by the global shift toward these therapies and driven by his father Rocky’s difficult experience during cancer treatment. That legacy lives on in ANTG’s patient-first approach and in the “Rocky” cultivar, which now offers potential relief to thousands of Australians.
From proprietary Australian genetics to fully integrated GACP and GMP-certified operations, ANTG leads with quality, care and community. Today, it stands as a trusted Australian alternative therapy provider and a key force in advancing sector-wide education, prescriber capability and global collaboration.
ANTG develops products grounded in scientific research and relevance
Proprietary genetics are designed to target specific conditions
Partnerships with institutions like the University of New England support ongoing innovation
Active clinical studies help build prescriber confidence and therapeutic trust
Every product is made to deliver reliable, standardised outcomes for patients
Scientific discovery is guided by real-world patient needs and potential therapeutic outcomes
Welcome to Canview
A facilitation agent for BHC.